Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 91

1.

Assessment of risk factors for increased resource utilization in kidney transplantation.

Vranian SC Jr, Covert KL, Mardis CR, McGillicuddy JW, Chavin KD, Dubay D, Taber DJ.

J Surg Res. 2017 Oct 31. pii: S0022-4804(17)30631-5. doi: 10.1016/j.jss.2017.09.037. [Epub ahead of print]

PMID:
29100587
2.

Valganciclovir (VGCV) followed by cytomegalovirus (CMV) hyperimmune globulin compared to VGCV for 200 days in abdominal organ transplant recipients at high risk for CMV infection: A prospective, randomized pilot study.

Fleming JN, Taber DJ, Weimert NA, Nadig S, McGillicuddy JW, Bratton CF, Baliga PK, Chavin KD.

Transpl Infect Dis. 2017 Sep 16. doi: 10.1111/tid.12779. [Epub ahead of print]

PMID:
28921781
3.

Improvement in immunosuppression therapy monitoring in organ transplant recipients.

Thrall SA, Fominaya CE, Chiasson JM, Castle S, Taber DJ.

Am J Health Syst Pharm. 2017 Sep 1;74(17 Supplement 3):S67-S74. doi: 10.2146/ajhp160872.

PMID:
28842520
4.

Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation.

Taber DJ, Su Z, Fleming JN, McGillicuddy JW, Posadas-Salas MA, Treiber FA, Dubay D, Srinivas TR, Mauldin PD, Moran WP, Baliga PK.

Transplantation. 2017 Jun 28. doi: 10.1097/TP.0000000000001840. [Epub ahead of print]

PMID:
28658199
5.

Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients.

Taber DJ, McGillicuddy JW, Bratton CF, Rohan VS, Nadig S, Dubay D, Baliga PK.

Ann Surg. 2017 Sep;266(3):450-456. doi: 10.1097/SLA.0000000000002366.

PMID:
28654544
6.

Morbid obesity and functional status as predictors of surgical complication after renal transplantation.

Veasey TM, Fleming JN, Strout SE, Miller R, Pilch NA, Meadows HB, Mardis CR, Mardis BA, Shenvi S, McGillicuddy J, Chavin KD, Baliga P, Taber DJ.

Am J Surg. 2017 Jun 8. pii: S0002-9610(17)30518-4. doi: 10.1016/j.amjsurg.2017.05.009. [Epub ahead of print]

PMID:
28622834
7.

Ambulatory Care Coordination Issues With Dual Use Veteran Organ Transplant Recipients.

Thrall SA, Egede LE, Taber DJ.

Prog Transplant. 2017 Jun;27(2):187-191. doi: 10.1177/1526924817699963. Epub 2017 Mar 24.

PMID:
28617159
8.

Impact of the New Kidney Allocation System on Perioperative Outcomes and Costs in Kidney Transplantation.

Taber DJ, DuBay D, McGillicuddy JW, Nadig S, Bratton CF, Chavin KD, Baliga PK.

J Am Coll Surg. 2017 Apr;224(4):585-592. doi: 10.1016/j.jamcollsurg.2016.12.009. Epub 2017 Jan 31.

PMID:
28159650
9.

Tacrolimus confers lower acute rejection rates and better renal allograft survival compared to cyclosporine.

Kamel M, Kadian M, Srinivas T, Taber D, Posadas Salas MA.

World J Transplant. 2016 Dec 24;6(4):697-702. doi: 10.5500/wjt.v6.i4.697.

10.

Development of a Predictive Model for Drug-Related Problems in Kidney Transplant Recipients.

Covert KL, Mardis CR, Fleming JN, Pilch NA, Meadows HB, Mardis BA, Mohan P, Posadas-Salas M, Srinivas T, Taber DJ.

Pharmacotherapy. 2017 Feb;37(2):159-169. doi: 10.1002/phar.1886. Epub 2017 Feb 3.

PMID:
27997676
11.

A Comparative Effectiveness Analysis of Early Steroid Withdrawal in Black Kidney Transplant Recipients.

Taber DJ, Hunt KJ, Gebregziabher M, Srinivas T, Chavin KD, Baliga PK, Egede LE.

Clin J Am Soc Nephrol. 2017 Jan 6;12(1):131-139. doi: 10.2215/CJN.04880516. Epub 2016 Dec 15.

PMID:
27979979
12.

The Impact of Health Care Appointment Non-Adherence on Graft Outcomes in Kidney Transplantation.

Taber DJ, Fleming JN, Fominaya CE, Gebregziabher M, Hunt KJ, Srinivas TR, Baliga PK, McGillicuddy JW, Egede LE.

Am J Nephrol. 2017;45(1):91-98. doi: 10.1159/000453554. Epub 2016 Dec 2.

PMID:
27907919
13.

Outcome disparities between African Americans and Caucasians in contemporary kidney transplant recipients.

Taber DJ, Egede LE, Baliga PK.

Am J Surg. 2017 Apr;213(4):666-672. doi: 10.1016/j.amjsurg.2016.11.024. Epub 2016 Nov 18.

PMID:
27887677
14.

Incidence and risk factors of hepatocellular carcinoma after orthotopic liver transplantation.

Colhoun ED 5th, Forsberg CG, Chavin KD, Baliga PK, Taber DJ.

Surgery. 2017 Mar;161(3):830-836. doi: 10.1016/j.surg.2016.08.049. Epub 2016 Oct 19.

PMID:
27771158
15.

Twenty years of evolving trends in racial disparities for adult kidney transplant recipients.

Taber DJ, Gebregziabher M, Hunt KJ, Srinivas T, Chavin KD, Baliga PK, Egede LE.

Kidney Int. 2016 Oct;90(4):878-87. doi: 10.1016/j.kint.2016.06.029. Epub 2016 Aug 20.

16.

Concern for Lost Income Following Donation Deters Some Patients From Talking to Potential Living Donors.

Rodrigue JR, Schold JD, Mandelbrot DA, Taber DJ, Phan V, Baliga PK.

Prog Transplant. 2016 Dec;26(4):292-298. doi: 10.1177/1526924816661332. Epub 2016 Aug 19.

PMID:
27495327
17.

Kidney transplant recipients' attitudes about using mobile health technology for managing and monitoring medication therapy.

Browning RB, McGillicuddy JW, Treiber FA, Taber DJ.

J Am Pharm Assoc (2003). 2016 Jul-Aug;56(4):450-454.e1. doi: 10.1016/j.japh.2016.03.017.

18.

Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients.

Taber DJ, Hunt KJ, Fominaya CE, Payne EH, Gebregziabher M, Srinivas TR, Baliga PK, Egede LE.

Hypertension. 2016 Sep;68(3):715-25. doi: 10.1161/HYPERTENSIONAHA.116.07775. Epub 2016 Jul 11.

19.

Depression, Resource Utilization, and Outcomes Following Liver Transplant.

Sebaaly JC, Fleming J, Pilch N, Meadows H, Finn A, Chavin K, Baliga P, Bratton CF, McGillicuddy JW, Nadig S, Taber D.

Prog Transplant. 2016 Sep;26(3):270-6. doi: 10.1177/1526924816654641. Epub 2016 Jun 13.

PMID:
27297232
20.

Transplanting Sensitized Kidney Transplant Patients With Equivalent Outcomes Utilizing Stringent HLA Crossmatching.

Rohan VS, Taber DJ, Moussa O, Pilch NA, Denmark S, Meadows HB, McGillicuddy JW, Chavin KD, Baliga PK, Bratton CF.

Exp Clin Transplant. 2017 Feb;15(1):47-55. doi: 10.6002/ect.2015.0274. Epub 2016 Jun 3.

Supplemental Content

Loading ...
Support Center